Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

RPR redirects development of PDE IV inhibitor

Nov. 21, 1997

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...